Monteris Medical has announced that the NeuroBlate system for MR-guided neurosurgical ablation will be presented to members and attendees at the biennial meeting of the American Society of Stereotactic and Functional Neurosurgery (31 May–3 June; Washington, DC, USA). Gene Barnett, director of the Rose Ella Burkhardt Brain Tumor and NeuroOncology Center at the Cleveland Clinic, will present his experience utilising NeuroBlate system laser ablation in patients with brain tumours and radiation necrosis.
Barnett and his colleagues have shown that by employing magnetic resonance (MR) imaging and software based visualisation offered by the NeuroBlate system they are often able to completely ablate tumours through a very small hole in the skull. They published their results in the May issue of the online Journal Cancer Medicine.
“We are pleased to have the NeuroBlate system included in this scientific meeting agenda,” says John E Schellhorn, president and chief executive officer of Monteris Medical. “Patients who have received this minimally invasive laser ablation therapy for brain lesions have gone to post-surgical recovery with a small bandage on their scalp rather than a large suture line. We are proud of our technology’s contribution to less-invasive brain surgery.”
